Aktuellt
SENASTE
OssDsign reported Catalyst sales of SEK 26.8m (10% vs SEB 24.4) 256% y/y growth, driven in part by extraordinary large orders of c. SEK 4m (we expected SEK 4.5m). Strong quarter was expected as the two first months had been pre-announced. On the cost side, NRIs from Cranial PSI discontinuation were SEK 20m (25% vs SEB 16m) and overall opex was 24% higher than our estimates. Mixed report given the strong top line but higher-than-expected costs. Mid-point SEK 10.
LÄS MER
